“Receiving the Clinician-Teacher Development Award is a testament to MGH and MGPO’s commitment to my career as a clinician, teacher and community leader. As an infectious disease physician, I help disadvantaged communities in Massachusetts through my work in the Mycobacterial Center, and the international health community through my project in HIV and tuberculosis in Peru. I am grateful for the generous support and mentoring that the CTDA has provided me, which was essential to the development of these projects and my career during these past four years.” - Rocío Hurtado, MD, DTM&H Director, Mycobacterial Center - Infectious Disease Unit First co-recipient, 2004 Clinician-Teacher Development Award
Clinician Teacher Development Award Recipients (2012-2004)
Jocelyn Carter, MD, MPH
Assistant in Medicine, General Internal Medicine Division,
Academic Hospitalist Service
Instructor of Medicine, Harvard Medical School
Jocelyn Carter, MD, MPH, obtained her BA from Harvard University in 2001 and her MD from the University of Illinois at Chicago College of Medicine in 2006. She completed her medical residency training at Dartmouth-Hitchcock Medical Center, Lebanon, NH in 2009. In 2011, she completed a Leadership Preventive Medicine Fellowship at Dartmouth-Hitchcock Medical Center and received her Masters in Public Health from The Dartmouth Institute for Health Policy and Clinical Practice in Lebanon, NH. Jocelyn joined the Academic Hospitalist Service within the Department of Medicine at the Massachusetts General Hospital in July 2011. Her clinical research at MGH currently includes implementation of inpatient care-centered innovations focused on improved care transitions as a part of a Commonwealth Fund/ Institute for Healthcare Improvement sponsored national initiative (STAAR). Recently, Jocelyn was honored to receive the 2012 Clinician Teacher Development Award (CTDA) sponsored by the MGH Multicultural Affairs Office/MGPO. With the CTDA, Jocelyn looks forward to studying readmission patterns and designing clinically based interventions that address peri-hospitalization quality gaps and lead to reduced readmission rates. She also enjoys serving as a preceptor for second year medical students enrolled in the Harvard Medical School Preceptor- Doctor II course and on the Department of Medicine’s Internship Selection Committee. Jocelyn is also a member of the Massachusetts Medical Society, the American Medical Association and is currently serves as a Harvard University Alumni Association mentor.
Abstract: Reducing 30-day Hospital Readmissions in an Academic Medical Center
The major project focus is the study of readmissions patters to reduce readmissions on the MGH Academic Hospitalist Service. In the era of health care reform and increasing emphasis on higher quality healthcare at lower costs, the importance of care delivery during and after hospitalizations has been magnified. With over 13 million hospitalizations driving $102 billion in health care costs in 2004, rates of hospitalization have become a measure of keen interest. In 2004, there were 2.3 million hospital readmissions (19%) among Medicare enrollees within 30 days of a previous discharge generating over $17 billion in health care costs. Up to $12 billion of these costs (70%) have been attributed to preventable rehospitalizations. The discovery and validation of meaningful interventions and analytic tools structured to reduce hospital readmissions and meet the needs of hospitalized populations remains understudied and additional resources are needed to create valuable solutions. Primary aims of this project include (1)validating an analytic tool that can be used to identify patients with increased risk for 30 day readmission; (2) characterizing the effect of interventions involving primary care providers and also accepting providers of patients at increased risk for readmissions at skilled nursing and rehabilitation facilities; and (3) examining the effect of patient-centered interventions for patient for patient at increased risk for readmissions. The results of this work are expected to contribute to protocols that may be provide critical insights and improved strategies of reducing hospital readmissions locally and nationally.
Luana Marques, PhD
Assistant in Psychology, Massachusetts General Hospital
Assistant Professor of Psychology in Psychiatry, Harvard Medical School
Dr. Luana Marques is the Director of the Hispanic Clinical and Research Program at the Massachusetts General Hospital and the Director for Research and Training program for the Center for Anxiety and Traumatic Stress Disorders (MGH), and an Assistant Professor of Psychology in Psychiatry at the Harvard Medical School. Dr. Marques completed her PhD in Clinical Psychology at the State University of New York (SUNY) at Buffalo and her clinical internship in the Cognitive Behavioral Track (CBT) at Massachusetts General Hospital/Harvard Medical School in 2007.
Dr. Marques’ major clinical and research interests include the treatment of anxiety disorders, with a particular focus on the implementation of empirically based treatments (EBTs) for patients suffering from various anxiety disorders in community health clinics (CMHCs). Dr. Marques’ ultimate research goal is to decrease disparities in care for psychiatric patients, especially among low-income and ethnic minority patients. Dr. Marques has extensive experience in treating patient with trauma and anxiety disorders utilizing a variety of empirically supported treatments such as prolonged exposure and various cognitive behavioral therapies. Dr. Marques is an active member of the Anxiety and Depression Association of America and the Association for the Advancement of Cognitive and Behavioral Therapy.
Abstract: Creating a Teaching Program for Evidence Based Therapy for PTSD in Community Mental Health: Bridging the Science-Practice Gap
The core aim of the proposed teaching plan is to bridge the science-practice gap, by creating a community participatory teaching program that is designed to teach an empirically-based treatment, namely Cognitive Processing Therapy (CPT), to clinicians who are actively treating patients diagnosed with posttraumatic stress disorder (PTSD) at the MGH-Chelsea Community Mental Health Center (MGH-Chelsea). PTSD is a highly prevalent disorder and is associated with significant individual and societal burden. Empirically based treatments (EBTs) for PTSD, such as CPT, have demonstrated efficacy and effectiveness. However, efforts to implement EBTs for PTSD in CMHCs have been largely ineffectual due, in part, to complex barriers to implementation. One such barrier is the lack of integration between academic medicine and clinical practice in the “real-world.” Often, even cutting-edge teachers and researchers fail to bring their knowledge into the typical practice settings, which in turn contributes to the average of 10 years gap between advances in science and practice in the clinic. The current project proposes to decrease the science-practice gap by applying the candidate’s clinical, teaching and research expertise to develop a means of effectively teaching cognitive processing therapy to community mental health workers (CMHWs) to ultimately improve clinical outcomes for patients suffering from PTSD. This CTDA award will allow the candidate to create a novel teaching curriculum designed
to bring EBT to community care settings.
Erica Wilson, MD
Attending Physician in Medicine, Division of Palliative Care
Instructor of Medicine, Harvard Medical School
Dr. Erica Wilson obtained her BA in Computer Science and Chemistry from Mount Holyoke College and her MD from the University of California San Francisco. She completed her internal medicine and chief residencies at Cambridge Hospital in Cambridge, MA. She received subspecialty training in the Harvard Palliative Medicine Fellowship and then joined the Massachusetts General Hospital Palliative Care service as an attending in September 2009. She currently is an instructor in Medicine at Harvard Medical School. Her interests include medical informatics, patient safety, cross cultural medicine and Palliative Medicine for the underserved. Her research focuses on Palliative Medicine for the homeless. She enjoys teaching and learning and spending time with her son.
Received the CTDA for her project entitled: Dying Without a Home: understanding and responding to disparities in palliative and end of life care among the homeless.
Abstract: Dying Without a Home: understanding and responding to disparities in palliative and end of life care among the homeless
The field of Palliative medicine strives to improve the quality of life of patients and their families facing life-threatening illness, through the prevention, assessment and treatment of pain and other physical, psychosocial and spiritual problems. Social inequity, especially poverty, is a major risk factor for people to experience both suffering and premature death. These very populations also have limited access to quality palliative and end of life care. There is a dearth of research to inform the development education, advocacy, public health and clinical innovation in these areas.
We will conduct semi-structured interviews of (3) homeless patients receiving end of life care at the Barbara McInnis House (BMH) in Boston. Interviews will focus on their experiences and the quality of care received as well as their attitudes and concerns about end of life to determine themes and the unique issues involved in dying without a home. We will conduct a chart review of the previous 3 patients who received end of life care and died at the BMH. We will enroll 20 terminally ill homeless patients receiving care the BMH and administer a survey about their attitudes and EOL concerns.
Using the combined clinical expertise of the Palliative Care Service (PCS) at Massachusetts General Hospital (MGH) and (BHCHP), we will create a curriculum and clinical protocols for providing palliative and end of life care to the homeless. Using the results of this work and the expertise within the MGH PCS in international palliative care, we will extend the Harvard Palliative Medicine Fellowship (HPMF) to also focus on the provision of care to marginalized patient populations such as homeless individuals and those in developing countries.
Wendy Macias Konstantopoulos, MD, MPH
Assistant Physician in Emergency Medicine
Instructor of Surgery, Harvard Medical School
Dr. Wendy Macías-Konstantopoulos, MD, MPH is a MGH board-certified emergency physician and instructor in the Department of Surgery at Harvard Medical School. She is Medical Director of the Human Trafficking Initiative in the Department of Emergency Medicine’s Division of Global Health & Human Rights. Dr. Macías-Konstantopoulos completed a Global Health Fellowship at the MGH Center for Global Health, volunteered with the International Organization for Migration’s Counter-Trafficking Unit in Indonesia, and represented the MGH Center for Global Health at the United Nations 2008 Global Forum to Fight Human Trafficking in Vienna, Austria. She is a member of the Massachusetts Medical Society’s Committee on Violence Intervention and Prevention, and a member of Physicians for Human Rights. She has lectured regionally and nationally at various forums on the topic of health and human trafficking.
Abstract: Redefining and Responding to Human Trafficking and Modern-day Slavery as Global Public Health Issues
Human trafficking and slavery have existed for centuries and continue to thrive today in a very clandestine way, seriously hampering attempts by leading international agencies to quantify the scope of the problem and challenging even the most imaginative of anti-trafficking efforts. Not only is enslavement a crime against humanity, it is an egregious affront on human rights that subjects its victims to various forms of mental, physical and sexual violence resulting in serious health consequences, including but not limited to an increased incidence of HIV – a public health threat to which the medical community must respond with a sense of urgency. The US is a major destination country for international trafficking and it has become increasingly evident that domestic trafficking of American children, from middle- and low-income families alike, for the purpose of commercial sexual exploitation is occurring almost undetected. This is a recognized problem in all major metropolitan port cities throughout the country and Boston is no exception. The goals of my research are: 1) carry out a comprehensive situational analysis of trafficking in Boston; 2) map out the current available health and social services to identify gaps and opportunities; 3) assess awareness of trafficking and slavery among local healthcare providers using both quantitative and qualitative methods; 4) raise awareness among medical trainees and healthcare providers through lectures and CME; and 5) identify ways in which the MGH can play a unique role in the prevention and intervention of victimization, as well as the delivery of much needed physical and mental health services. With assistance from NIH, as well as US State Department funds that have been specifically set aside for this underserved and vulnerable population, my long-term vision is to usher an MGH response that is akin to the Bellevue-NYU Program for Survivors of Torture.
Alexy Arauz-Boudreau, MD, MPH
Assistant in Pediatrics
Instructor of Pediatrics, Harvard Medical School
Dr. Arauz Boudreau is an academic community pediatrician with the MGH Center for Adolescent and Child Health Research and Policy and practices as a primary care pediatrician at MGH Chelsea HealthCare Center. She is an Associate Director of the MGH Multicultural Affairs Office. She received her medical degree from Harvard Medical School and a Masters in Public Health from Harvard School Public Health. She has completed the Harvard Pediatric Health Services Research Fellowship and the Commonwealth Fund Mongan Fellowship in Minority Health Policy.
Dr. Arauz Boudreau’s interests focus on determining effective means to reduce health disparities for vulnerable children by impacting childhood development both through community and primary care initiatives. She studies elements required to structure pediatric practices to successfully influence child development making an impact on school readiness and life style behaviors with the aspiration of influencing life long health trajectories and reducing disparities. Current projects involve understanding how practices transform into a medical home and aim to use the medical home concept as a platform to transform pediatric practice into a holistic system for promoting child development and addressing health disparities. Dr. Arauz Boudreau has served on committees for initiatives that foster healthy child development among vulnerable children.
Abstract: The Evaluation of Healthy Steps MGH: Promoting Healthy Child Development and the Reduction of Health Disparities Through an Office Based Intervention
Background: Early life experiences are important in predicting the emotional and physical well being of both children and adults. By setting life-health trajectories, early childhood influences health disparities and offers an opportunity to address disparities through enhancing childhood development. Healthy Steps is one model by which pediatricians can augment preventative childhood health and development. It places child developmental specialists in pediatric practices, coupling well-child visits with parental education.
Objective: We aim to explore the effects of Healthy Steps on child development and how it may affect school readiness, obesity, mental health and disparities in these outcomes.
Design: A case-control study of the MGH Healthy Steps will assess differences among families that receive Healthy Steps and those that do not, as well as differences across racial/ethnic and socio-economic groups. One hundred cases families and 300 controls (1:3 case:control) that speak either English or Spanish will be enrolled prior to the child’s four-year-old well-child visit. Outcomes will be assessed using established instruments to compare scores across groups.
Implications: By demonstrating that developmental specialists can assist pediatricians in improving school readiness and reducing precursors of obesity and mental health, we can move beyond describing health disparities to reducing them and argue for preventative health interventions focused on early childhood.
J. Carl Pallais, MD, MPH
Director, Endocrine Elective Course
Subspecialty Education Coordinator, Department of Medicine
Assistant Professor of Medicine, Harvard Medical School
Dr. J. Carl Pallais received his BA in Biology in 1993 from the Johns Hopkins University and his MD in 1999 from the Johns Hopkins School of Medicine. Prior to starting his medicine residency, Dr. Pallais received his MPH degree from the Harvard School of Public Health and conducted research in immunology as a Howard Hughes Research Fellow. He completed his Internal Medicine residency training at MGH in 2002 and was recognized for his teaching and clinical skills. He received the “Excellence in Teaching Award” and served as Chief Resident in 2003-2004. He subsequently completed his clinical and research fellowship in endocrinology at MGH in 2005 and stayed at MGH as a member of the clinical and research staff in the Endocrine Unit. Working with patients as well as knockout mice, he has studied the biology underlying autoimmune hyperparathyroidism, explored the neuroendocrine regulation of the reproductive axis, and examined the effects of testosterone on a number of physiologic functions in men. In 2006, he joined the Inpatient Clinician Educator Service in the Department of Medicine and has worked with faculty members at MGH and the Broad Institute to incorporate genetics education into clinical training. He continues to be an active member of the Endocrine Unit and also serves as a Subspecialty Education Coordinator for the Department of Medicine.
Abstract: Development of a Genetics Curriculum for the Internal Medicine Residency Program
Since the completion of the Human Genome Project, advances in genetics have accelerated at an exponential rate. With a continued drop in utilization costs and the development of increasingly powerful genomic tools, genetics is destined to transform clinical medicine. Yet relatively few resources are currently devoted to enhancing genetics education for clinicians. I set out to develop a multifaceted curriculum to incorporate genetics into the existing educational framework of the Internal Medicine Residency Program. In addition to creating an assessment tool to track genetics literacy among residents, I was able to tap the vast institutional resources at MGH to enhance residents’ exposure to clinically relevant genetic principles during the course of their training. This entailed organizing didactic sessions, creating new clinical rotations, and developing educational tools geared for various levels of genetics experience. In addition, I was able to increase residents’ access to faculty members conducting genetics research and facilitate mentorship opportunities for residents interested in genetics.
Bisola Ojikutu, MD, MPH
Assistant in Medicine, Division of Infectious Diseases
Assistant Professor of Medicine, Harvard Medical School
Dr. Ojikutu has dedicated her career to rectifying disparities in health care access for HIVinfected patients both domestically and abroad. As Director of the Office of International Programs at Harvard Medical School she led initiatives to improve provision and systems of HIV care, increase care and treatment for women and children train health care workers and integrate HIV management into primary health systems in sub Saharan Africa. In that capacity she is the founding director of the Umndeni “Family” Care Program in KwaZulu Natal, South Africa. Domestically, she is an advocate for the health needs of minority populations living with HIV and has worked in consultation with the Massachusetts Department of Public Health to improve access to care for HIVinfected patients. She is also the Vice Chairman of the board of AIDS Action Committee of Massachusetts and serves as a faculty advisor for a number of community based organizations. Currently, she is an Assistant Professor of Medicine and maintains a clinical practice in the Infectious Disease Division at Massachusetts General Hospital. In addition, she is a Senior Advisor with John Snow Research and Training Institute where she is responsible for United States Agency for International Development (USAID) funded HIV/AIDS projects assessing models of care and conducting operations research through sub Saharan Africa.
Dr. Ojikutu holds an MD from the Johns Hopkins University School of Medicine, is an alumni of the Commonwealth Fund/Harvard University Fellowship in Minority Health Policy and holds an MPH from the Harvard School of Public Health. She completed internal medicine residency at Cornell’s New York Presbyterian Hospital and infectious disease fellowship at the Massachusetts General Hospital/Brigham and Women’s Hospital Program.
Abstract: Reaching Rural Communities: Establishment and Evaluation of a Community-Based Model of
HIV/AIDS Care and Treatment in Kwa-Zulu Natal, South African
The Umndeni “Family” Care Program (UCP) is a pilot initiative designed to increase access to HIV care and treatment for children orphaned by AIDS and their caregivers living in KwaXimba, a rural region in South Africa. UCP is a collaboration between Harvard, Valley Trust NGO, and Habitat for Humanity (HFH) AIDS Orphan Housing Program. Through this program, approximately 500 adults and children living in 70 households will have new homes built through HFH. In addition, they will be offered HIV testing, treatment, and ongoing prevention and adherence support if antiretroviral therapy is initiated through programs operated by Harvard and Valley Trust. In order to increase capacity for HIV treatment in this rural region and ensure programmatic sustainability, nurses, lay counselors and community health care workers will be trained at two remote clinic sites by nurses and doctors from Harvard affiliated hospitals. This site will also serve as a training site for Harvard Medical students and students at the Nelson Mandela School of Medicine.
Marcela G. del Carmen, MD, MPH
Associate in Gynecology and Obstetrics
Associate Professor, Harvard Medical School
Marcela del Carmen, MD, received her BS from Emory Universit,Atlanta, GA, in 1991 and Medical degree from Johns Hopkins University School of Medicine in 1995. She completed a residency in Gynecology and Obstetrics at Johns Hopkins Hospital in 1999 and Masters in Public Health from the Harvard School of Public Health in 2006. In 2002, after completing her fellowship in gynecologic oncology at MGH, Marcela left to go back to Johns Hopkins as an Assistant Professor, Department of Gynecology and Obstetrics, but a few years later, in 2003, MGH managed to recruit her back as an Assistant Professor in the Department of Obstetrics and Gynecology. She is currently serving as the Clinical Director for the Division of Gynecologic Oncology. She is the winner of numerous awards for her outstanding performance as a surgeon and teacher. Most recently, she is the recipient of the MGH Clinician-Teacher Development Award, a career development award sponsored by MAO, the President’s Office and MGPO, for Dr. del Carmen to embark in an educational and community project to advance as a clinician-teacher at MGH and HMS. Her current research interests focus on understanding barriers to Cervical Cancer screening in the Latina population being served by MGH.
Abstract: Understanding Barriers to Cervical Cancer Screening Among Hispanic Women in Boston
Latino women in the United States disproportionately shoulder the burden of cervical cancer. The higher incidence of cervical cancer which has been documented among Latino women in the United States is partly due to the lower rates of participation with Pap smear screening programs among Latino women in the United States. The project’s hypothesis is that improving compliance with Pap smear screening among Latino women necessitates the design of more culturally appropriate educational materials to better disseminate information about the role of Pap smear screening in the prevention of cervical carcinoma. In addition, it is also hypothesized that elimination of the currently existing disparities in health care mandates the institution and dissemination of culturally competent skills among health care providers. The funding from the Clinician-Teacher Development Award has the three following interrelated goals:
1. To investigate the demographics of screening that Latino women in the Boston area and their perception of the role of Pap smears in cervical cancer screening;
2. To design educational materials and health promotion strategies that best meet the needs of the Latino community in the Boston area and to evaluate the effectiveness of these materials and strategies in increasing compliance with Pap smear screening in a defined community-based cohort;
3. To design a culturally competent curriculum to educate health care givers who provide cervical cancer screening to
Rocío Hurtado, MD, DTM&H, FIDSA
Director, Mycobacterial Center - ID Unit, MGH
Associate Program Director for Global Health, Department of Medicine, MGH
Instructor of Medicine, Harvard Medical School.
Rocío Hurtado, MD, DTM&H, is an Infectious Disease physician at the ID Unit at MGH. She trained in Internal Medicine at MGH, with subsequent ID training at MGH and BWH including an HIV fellowship. She has additional Tropical Medicine training from the Liverpool School of Tropical Medicine in the United Kingdom. Rocio has extensive clinical and programmatic experience in the management of multi-drug resistant tuberculosis and HIV-TB coinfection in resource-limited settings through her work overseas which includes Peru, Uganda, South Africa and Ethiopia. She is currently the Clinical and Technical Advisor for the Global Health Committee program for MDRTB treatment in Ethiopia (a treatment program in partnership with the Ethiopian Ministry of Health). She is currently the Director of the Mycobacterial Center at MGH, and is also the Associate Program Director for Global Health in the Dept of Medicine at MGH. She is the recipient of several awards, including the Edward Kass Award in Clinical Excellence (Mass ID Society) and the Brian McGovern Award for Clinical Excellence at MGH (2011).
Abstract: A Clinical and Teaching Service Project for Mycobacterial Disease and HIV coinfections
With the support of her MGH Development award and mentorship from Drs. Nesli Basgoz and Paul Farmer, Rocio Hurtado’s proposed project has 2 stages. The first phase of her award has been dedicated to implementing the MGH’s Mycobacterial Center which provides centralized clinical care for patients living with Mycobacterial diseases (including TB, non-tuberculous mycobacteria and Hansen’s disease), cross-disciplinary expertise and clinical teaching (through Mycobacterial training of ID fellows and monthly multidisciplinary Case Conferences including multiple subspecialties at MGH). In the second phase of her project, she is developing a locally-relevant HIV/TB didactic module in conjunction with the Peruvian Ministry of Health, to later serve as a platform for training of different health-care sectors and which can be modified & adapted to other resource limited settings.